The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Tucked into the bipartisan budget deal that President-elect Donald Trump’s allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America’s drug ...